EC Healthcare (HKG:2138)
0.6300
-0.0200 (-3.08%)
Jun 13, 2025, 4:08 PM HKT
EC Healthcare Revenue
EC Healthcare had revenue of 2.06B HKD in the half year ending September 30, 2024, with 8.96% growth. This brings the company's revenue in the last twelve months to 4.15B, up 1.20% year-over-year. In the fiscal year ending March 31, 2024, EC Healthcare had annual revenue of 4.21B with 8.66% growth.
Revenue (ttm)
4.15B
Revenue Growth
+1.20%
P/S Ratio
0.18
Revenue / Employee
1.45M
Employees
2,611
Market Cap
746.68M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 4.21B | 335.66M | 8.66% |
Mar 31, 2023 | 3.88B | 955.88M | 32.74% |
Mar 31, 2022 | 2.92B | 839.10M | 40.33% |
Mar 31, 2021 | 2.08B | 131.90M | 6.77% |
Mar 31, 2020 | 1.95B | 96.05M | 5.18% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeOne Medicines | 32.53B |
Hansoh Pharmaceutical Group Company | 13.05B |
Innovent Biologics | 10.03B |
JD Health International | 61.89B |
WuXi Biologics | 19.87B |
CSPC Pharmaceutical Group | 28.99B |
Sino Biopharmaceutical | 30.72B |
Akeso | 2.26B |